Hideaki Tsuji
Overview
Explore the profile of Hideaki Tsuji including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
79
Citations
835
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yoshida A, Murakami K, Tsukamoto H, Hotta Y, Nakayama Y, Saito R, et al.
Mod Rheumatol
. 2025 Mar;
PMID: 40048675
Objectives: Polyunsaturated fatty acids (PUFAs) are healthy fats that contain a double carbon bond. They are made up of omega (ω)-3 and ω-6 PUFAs, where ω-3 PUFAs exhibit beneficial effects,...
2.
Sasai T, Hiwa R, Kachi S, Shimizu Y, Yamamoto S, Teramoto Y, et al.
Mod Rheumatol Case Rep
. 2025 Mar;
PMID: 40045600
Sarcoidosis is a multisystem disorder characterized by non-caseating granulomas, often involving the lungs and lymph nodes, but can affect nearly any organ. Renal involvement in sarcoidosis typically presents as hypercalcemia...
3.
Nakakubo Y, Tsuji H, Takase Y, Yoshida T, Kozuki T, Iwasaki T, et al.
Kobe J Med Sci
. 2025 Feb;
70(4):E113-E124.
PMID: 39993784
Objectives: To analyse the association of anti-dsDNA Ab with patient-reported outcomes (PROs) in patients with SLE under maintenance treatment, as it has not been clearly understood whether PROs are able...
4.
Iwasaki T, Yoshifuji H, Kitagori K, Sumitomo S, Akizuki S, Nakashima R, et al.
Front Immunol
. 2025 Feb;
16:1506298.
PMID: 39975549
The factors contributing to the treatment efficacy of belimumab in patients with systemic lupus erythematosus (SLE) in the maintenance phase are unknown. Here, we collected blood samples from patients with...
5.
Tsuji H, Shirakashi M, Hiwa R, Akizuki S, Nakashima R, Onishi A, et al.
Mod Rheumatol
. 2025 Jan;
PMID: 39821063
[Objective] To investigate differences in autoantibodies, clinical features, and long-term outcomes between juvenile- and adult-onset systemic sclerosis (SSc). [Methods] Autoantibodies and survival rates over a maximum of 20 years were...
6.
Sasai T, Nakashima R, Handa T, Yamano Y, Kondo Y, Matsuda S, et al.
Clin Immunol
. 2024 Oct;
268():110372.
PMID: 39357632
Autoantibodies are detected in idiopathic interstitial pneumonias (IIPs) without a clear connective tissue disease diagnosis, and their clinical significance is unclear. This study aimed to identify a novel autoantibody in...
7.
Doi H, Ohmura K, Hashimoto M, Ueno K, Takase Y, Inaba R, et al.
Lupus
. 2024 Sep;
33(12):1336-1344.
PMID: 39276161
Objectives: There are often discrepancies in the evaluation of disease activity between patients and physicians in systemic lupus erythematosus (SLE). In this study, we examined the factors that affect those...
8.
Tsuji H, Nakashima R, Yasumi T, Sasai T, Ichimura Y, Shirakashi M, et al.
Semin Arthritis Rheum
. 2024 Aug;
68:152530.
PMID: 39142036
Objective: To investigate differences in autoantibodies, clinical features, and long-term outcomes between juvenile-idiopathic inflammatory myopathy (IIM) and adult-IIM METHODS: Autoantibodies, clinical characteristics, and drug-free conditions for a maximum of 20...
9.
Naito R, Hiwa R, Inaba R, Murakami K, Kitoh A, Kaku Y, et al.
Mod Rheumatol Case Rep
. 2024 Aug;
9(1):84-87.
PMID: 39087257
Vesiculobullous dermatomyositis (VD) is a rare manifestation of dermatomyositis (DM) and has been suggested to be associated with malignancy. Although the myositis-specific autoantibodies are associated with distinct clinical presentations of...
10.
Nose Y, Onishi A, Nishimura K, Yamamoto Y, Sada K, Ichinose K, et al.
Rheumatology (Oxford)
. 2024 Jun;
PMID: 38885408
Objectives: The predictive validity of disease-specific quality of life (QOL) remains unknown in patients with systemic lupus erythematosus (SLE), although disease-specific measures are equally or more responsive to changes than...